Physician
Hematology
Dr. Dennis L. Confer, MD
|
|
Give Review
Doctor Dennis L. Confer, MD works in the field of Hematology. Dennis Confer has written publications. He has 93 publications published with PubMed. The lastest paper is: 'G-CSF-mobilized donor leukocyte infusions as immunotherapy in acute leukemia relapsing after allogeneic marrow transplantation.'
Publications
- European Group for Blood and Marrow Transplantation Centers with FACT-JACIE Accreditation Have Significantly Better Compliance with Related Donor Care Standards.
- Significant Improvements in the Practice Patterns of Adult Related Donor Care in US Transplantation Centers.
- On Modeling Human Leukocyte Antigen-Identical Sibling Match Probability for Allogeneic Hematopoietic Cell Transplantation: Estimating the Need for an Unrelated Donor S...
- Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors.
- The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy.
- A review of the genetic and long-term effects of G-CSF injections in healthy donors: a reassuring lack of evidence for the development of haematological malignancies.
- Recommendations for donor human leukocyte antigen assessment and matching for allogeneic stem cell transplantation: consensus opinion of the Blood and Marrow Transplan...
- Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells from unrelated donors, a Center for Inter...
- Significant improvement in survival after unrelated donor hematopoietic cell transplantation in the recent era.
- 8/8 and 10/10 High-resolution match rate for the Be The Match Unrelated Donor Registry.
- Improved Survival After Transplantation of More Donor Plasmacytoid Dendritic or Naïve T Cells From Unrelated-Donor Marrow Grafts: Results From BMTCTN 0201.
- Lower risk of serious adverse events and no increased risk of cancer after PBSC versus bone marrow donation.
- Health-related Quality of Life of Bone Marrow versus Peripheral Blood Stem Cell Donors: A Prespecified Subgroup Analysis from a Phase III RCT-BMTCTN Protocol 0201.
- Multiple mismatches at the low expression HLA loci DP, DQ, DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation.
- Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program.
- Radiation Disasters: Role of the BMT Team.
- Planning and Response to Radiation Exposures.
- Assessing surge capacity for radiation victims with marrow toxicity.
- Medical management of radiation victims in the United States.
- Selection of adult unrelated hematopoietic stem cell donors: beyond HLA.
- Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose.
- Rapid transport and infusion of hematopoietic cells is associated with improved outcome after myeloablative therapy and unrelated donor transplant.
- Stem cells, multiorgan failure in radiation emergency medical preparedness: a U.S./European Consultation Workshop.
- Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program.
- Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program.
- Twenty years of unrelated donor bone marrow transplantation for pediatric acute leukemia facilitated by the National Marrow Donor Program.
- National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants.
- Radiologic and nuclear events: contingency planning for hematologists/oncologists.
- Principles and tools for selection of umbilical cord blood and unrelated adult donor grafts.
- High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.
- Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival.
- HLA mismatching within or outside of cross-reactive groups (CREGs) is associated with similar outcomes after unrelated hematopoietic stem cell transplantation.
- Advances in HLA: practical implications for selecting adult donors and cord blood units.
- Ethnic differences in donation-related characteristics among potential hematopoietic stem cell donors.
- Evaluation of hematopoietic stem cell donors.
- Attrition of potential bone marrow donors at two key decision points leading to donation.
- The association of donor center characteristics with attrition from the national marrow donor registry.
- National Marrow Donor Program HLA-matching guidelines for unrelated marrow transplants.
- Factors associated with ambivalence about bone marrow donation among newly recruited unrelated potential donors.
- Radiation injury treatment network (RITN): healthcare professionals preparing for a mass casualty radiological or nuclear incident.
- Hematopoietic cell graft safety.
- The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant rese...
- Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival.
- Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong a...
- Blood and marrow transplant clinical trials network (BMT CTN): addressing unanswered questions.
- Characterization of baboon class I major histocompatibility molecules. Implications for baboon-to-human xenotransplantation.
- Hematopoietic growth factors--use in normal blood and stem cell donors: clinical and ethical issues.
- Unrelated donor stem cell transplantation: the role of the National Marrow Donor Program.
- The US National Marrow Donor Program role in unrelated donor hematopoietic cell transplantation.
- The effect of the composition of unrelated donor bone marrow and peripheral blood progenitor cell grafts on transplantation outcomes.
- Validation of short-term handling and storage conditions for marrow and peripheral blood stem cell products.
- Effects of granulocyte-colony stimulating factor on chromosome aneuploidy and replication asynchrony in healthy peripheral blood stem cell donors.
- Acute radiation injury: contingency planning for triage, supportive care, and transplantation.
- Allogeneic transplant physician and center capacity in the United States.
- Unrelated donor hematopoietic cell transplantation: factors associated with a better HLA match.
- Donor safety: the role of the WMDA in ensuring the safety of volunteer unrelated donors: clinical and ethical considerations.
- Preparing for the unthinkable: emergency preparedness for the hematopoietic cell transplant program.
- Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the national marrow donor program.
- Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age.
- Non-HLA barriers to unrelated donor stem cell transplantation.
- Non-conservative substitutions distinguish previously uncharacterized HLA-A molecules.
- The National Marrow Donor Program. Meeting the needs of the medically underserved.
- The National Marrow Donor Program: improving access to hematopoietic stem cell transplantation.
- Peripheral blood progenitor cells for HPC transplants involving unrelated donors.
- G-CSF-mobilized donor leukocyte infusions as immunotherapy in acute leukemia relapsing after allogeneic marrow transplantation.
- Sequence-based typing provides a new look at HLA-C diversity.
- Long-term results of autologous marrow transplantation for relapsed or refractory male or female germ cell tumors.
- Unrelated marrow donor registries.
- Cytomegalovirus surveillance and prevention in allogeneic bone marrow transplantation: examination of a preemptive plan of ganciclovir therapy.
- High-dose carboplatin, etoposide and cyclophosphamide with autologous bone marrow transplantation for the treatment of advanced malignancies: a phase I study.
- Allogeneic bone marrow transplantation: experience with 92 patients.
- Autologous bone marrow transplantation for metastatic breast cancer.
- Autologous bone marrow transplantation for non-Hodgkin lymphoma.
- Long-term survival after autologous bone marrow transplantation for metastatic breast carcinoma.
- Bordetella adenylate cyclase toxin: entry of bacterial adenylate cyclase into mammalian cells.
- Pathogen-host jujitsu: phagocyte impotence caused by internalized bacterial adenylate cyclase.
- Phagocyte impotence caused by an invasive bacterial adenylate cyclase.
- Antineoplastic effects of Bordetella pertussis adenylate cyclase.
- Bordetella adenylate cyclase: host toxicity and diagnostic utility.
- Rapid transcriptional down-regulation of c-myc expression during cyclic adenosine monophosphate-promoted differentiation of leukemic cells.
- Rapid diagnosis of pertussis.
- Herpes simplex virus-infected cells disarm killer lymphocytes.
- Medical management of the acute radiation syndrome: recommendations of the Strategic National Stockpile Radiation Working Group.
- State of the art review: HLA matching and outcome of unrelated donor umbilical cord blood transplants.
- Long-term safety of filgrastim (rhG-CSF) administration.
- Ellipsometer nulling: convergence and speed.
- Practice patterns for evaluation, consent, and care of related donors and recipients at hematopoietic cell transplantation centers in the United States.
- Unrelated hematopoietic stem cell donors as research subjects.
- WMDA guidelines for subsequent donations following initial BM or PBSCs.
- Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation.
- Concerns about the use of biosimilar granulocyte colony-stimulating factors for the mobilization of stem cells in normal donors: position of the World Marrow Donor Ass...
- Recovery of Unrelated Donors of Peripheral Blood Stem Cells versus Bone Marrow: A Prespecified Analysis from the Phase III BMT CTN Protocol 0201.
Doctors Specialties
- Hematology
Accepted Insurances
Helpful Reviews
Similar Doctors
|
|
Dr. Stuart H. Bloom, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark R. Menge, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cathleen Chen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rachel E. Lerner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dennis L. Confer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Smitha P. Menon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hector A. Mesa-Corrales, MD |
|
|
Dr. Kathleen V. Watson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Craig E. Eckfeldt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Laura E. Moench, MD |
|
|
Dr. Fatih M. Uckun, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|